335 related articles for article (PubMed ID: 25895126)
1. Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.
Al-Wahab Z; Mert I; Tebbe C; Chhina J; Hijaz M; Morris RT; Ali-Fehmi R; Giri S; Munkarah AR; Rattan R
Oncotarget; 2015 May; 6(13):10908-23. PubMed ID: 25895126
[TBL] [Abstract][Full Text] [Related]
2. Dietary energy balance modulates ovarian cancer progression and metastasis.
Al-Wahab Z; Tebbe C; Chhina J; Dar SA; Morris RT; Ali-Fehmi R; Giri S; Munkarah AR; Rattan R
Oncotarget; 2014 Aug; 5(15):6063-75. PubMed ID: 25026276
[TBL] [Abstract][Full Text] [Related]
3. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy.
Phoenix KN; Vumbaca F; Fox MM; Evans R; Claffey KP
Breast Cancer Res Treat; 2010 Sep; 123(2):333-44. PubMed ID: 20204498
[TBL] [Abstract][Full Text] [Related]
4. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
[TBL] [Abstract][Full Text] [Related]
5. Alleviation of senescence and epithelial-mesenchymal transition in aging kidney by short-term caloric restriction and caloric restriction mimetics via modulation of AMPK/mTOR signaling.
Dong D; Cai GY; Ning YC; Wang JC; Lv Y; Hong Q; Cui SY; Fu B; Guo YN; Chen XM
Oncotarget; 2017 Mar; 8(10):16109-16121. PubMed ID: 28147330
[TBL] [Abstract][Full Text] [Related]
6. Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway.
Liao H; Zhou Q; Gu Y; Duan T; Feng Y
Oncol Rep; 2012 Jun; 27(6):1873-8. PubMed ID: 22469973
[TBL] [Abstract][Full Text] [Related]
7. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
8. Metformin alleviated endotoxemia-induced acute lung injury via restoring AMPK-dependent suppression of mTOR.
Wu K; Tian R; Huang J; Yang Y; Dai J; Jiang R; Zhang L
Chem Biol Interact; 2018 Aug; 291():1-6. PubMed ID: 29859833
[TBL] [Abstract][Full Text] [Related]
9. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
[TBL] [Abstract][Full Text] [Related]
10. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.
Rattan R; Giri S; Hartmann LC; Shridhar V
J Cell Mol Med; 2011 Jan; 15(1):166-78. PubMed ID: 19874425
[TBL] [Abstract][Full Text] [Related]
11. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
[TBL] [Abstract][Full Text] [Related]
12. The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.
De Angel RE; Conti CJ; Wheatley KE; Brenner AJ; Otto G; Degraffenried LA; Hursting SD
Mol Carcinog; 2013 Jun; 52(6):446-58. PubMed ID: 22290600
[TBL] [Abstract][Full Text] [Related]
13. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
[TBL] [Abstract][Full Text] [Related]
14. Genetic reduction of insulin-like growth factor-1 mimics the anticancer effects of calorie restriction on cyclooxygenase-2-driven pancreatic neoplasia.
Lashinger LM; Malone LM; McArthur MJ; Goldberg JA; Daniels EA; Pavone A; Colby JK; Smith NC; Perkins SN; Fischer SM; Hursting SD
Cancer Prev Res (Phila); 2011 Jul; 4(7):1030-40. PubMed ID: 21593196
[TBL] [Abstract][Full Text] [Related]
15. Effect of caloric restriction on the SIRT1/mTOR signaling pathways in senile mice.
Ma L; Dong W; Wang R; Li Y; Xu B; Zhang J; Zhao Z; Wang Y
Brain Res Bull; 2015 Jul; 116():67-72. PubMed ID: 26135885
[TBL] [Abstract][Full Text] [Related]
16. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
[TBL] [Abstract][Full Text] [Related]
17. Metformin Plus Caloric Restriction Show Anti-epileptic Effects Mediated by mTOR Pathway Inhibition.
Rubio Osornio MDC; Custodio Ramírez V; Calderón Gámez D; Paz Tres C; Carvajal Aguilera KG; Phillips Farfán BV
Cell Mol Neurobiol; 2018 Oct; 38(7):1425-1438. PubMed ID: 30132243
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.
Lengyel E; Litchfield LM; Mitra AK; Nieman KM; Mukherjee A; Zhang Y; Johnson A; Bradaric M; Lee W; Romero IL
Am J Obstet Gynecol; 2015 Apr; 212(4):479.e1-479.e10. PubMed ID: 25446664
[TBL] [Abstract][Full Text] [Related]
19. Loss of AMP-activated protein kinase-α2 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle.
Wang P; Zhang RY; Song J; Guan YF; Xu TY; Du H; Viollet B; Miao CY
Diabetes; 2012 May; 61(5):1051-61. PubMed ID: 22396207
[TBL] [Abstract][Full Text] [Related]
20. Leucine amplifies the effects of metformin on insulin sensitivity and glycemic control in diet-induced obese mice.
Fu L; Bruckbauer A; Li F; Cao Q; Cui X; Wu R; Shi H; Zemel MB; Xue B
Metabolism; 2015 Jul; 64(7):845-56. PubMed ID: 25858853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
